# Intraoperative Amiodarone to Prevent Atrial Fibrillation in Lung Transplant Patients

> **NCT03221764** · PHASE2 · COMPLETED · sponsor: **University of Louisville** · enrollment: 20 (actual)

## Conditions studied

- Atrial Fibrillation
- Lung Transplant; Complications

## Interventions

- **DRUG:** Amiodarone with CoSeal
- **DEVICE:** CO2 driver

## Key facts

- **NCT ID:** NCT03221764
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-19
- **Primary completion:** 2019-02-01
- **Final completion:** 2019-04-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03221764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03221764, "Intraoperative Amiodarone to Prevent Atrial Fibrillation in Lung Transplant Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03221764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*